A detailed history of Carmignac Gestion transactions in Danaher Corp stock. As of the latest transaction made, Carmignac Gestion holds 92,173 shares of DHR stock, worth $22.2 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
92,173
Previous 186,130 50.48%
Holding current value
$22.2 Million
Previous $46.5 Million 44.9%
% of portfolio
0.44%
Previous 0.81%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$239.25 - $280.76 $22.5 Million - $26.4 Million
-93,957 Reduced 50.48%
92,173 $25.6 Million
Q2 2024

Aug 13, 2024

BUY
$235.51 - $267.98 $24.1 Million - $27.4 Million
102,394 Added 122.28%
186,130 $46.5 Million
Q1 2024

May 14, 2024

BUY
$224.58 - $256.19 $2.3 Million - $2.62 Million
10,244 Added 13.94%
83,736 $20.9 Million
Q4 2023

Feb 13, 2024

SELL
$185.1 - $233.13 $1.99 Million - $2.51 Million
-10,776 Reduced 12.79%
73,492 $17 Million
Q3 2023

Nov 13, 2023

SELL
$233.08 - $265.59 $4.82 Million - $5.49 Million
-20,686 Reduced 19.71%
84,268 $20.9 Million
Q2 2023

Aug 11, 2023

BUY
$224.99 - $256.14 $5.63 Million - $6.41 Million
25,010 Added 31.28%
104,954 $25.2 Million
Q1 2023

May 12, 2023

SELL
$239.75 - $277.0 $157 Million - $181 Million
-653,163 Reduced 89.1%
79,944 $20.1 Million
Q4 2022

Feb 13, 2023

SELL
$241.42 - $282.29 $18.8 Million - $21.9 Million
-77,711 Reduced 9.58%
733,107 $195 Million
Q3 2022

Nov 10, 2022

SELL
$247.06 - $1507.4 $21.2 Million - $129 Million
-85,735 Reduced 9.56%
810,818 $209 Million
Q2 2022

Aug 12, 2022

BUY
$237.11 - $299.66 $21.1 Million - $26.6 Million
88,858 Added 11.0%
896,553 $227 Million
Q1 2022

May 13, 2022

BUY
$257.27 - $315.76 $33.3 Million - $40.9 Million
129,377 Added 19.07%
807,695 $237 Million
Q4 2021

Feb 11, 2022

BUY
$292.08 - $329.01 $181 Million - $204 Million
619,018 Added 1043.88%
678,318 $223 Million
Q3 2021

Nov 12, 2021

BUY
$272.21 - $332.43 $19,599 - $23,934
72 Added 0.12%
59,300 $18.1 Million
Q2 2021

Aug 13, 2021

SELL
$225.08 - $271.69 $801,284 - $967,216
-3,560 Reduced 5.67%
59,228 $15.9 Million
Q1 2021

May 14, 2021

BUY
$212.38 - $245.9 $2.1 Million - $2.43 Million
9,881 Added 18.68%
62,788 $14.1 Million
Q3 2020

Nov 13, 2020

SELL
$177.16 - $215.33 $170,782 - $207,578
-964 Reduced 1.79%
52,907 $11.4 Million
Q2 2020

Aug 13, 2020

BUY
$128.7 - $176.83 $6.26 Million - $8.6 Million
48,609 Added 923.77%
53,871 $9.53 Million
Q1 2020

May 14, 2020

BUY
$121.39 - $169.05 $48,313 - $67,281
398 Added 8.18%
5,262 $728,000
Q4 2019

Feb 13, 2020

BUY
$133.47 - $153.48 $333,007 - $382,932
2,495 Added 105.32%
4,864 $747,000
Q3 2019

Nov 13, 2019

BUY
$135.4 - $146.47 $33,985 - $36,763
251 Added 11.85%
2,369 $342,000
Q2 2019

Aug 13, 2019

BUY
$124.88 - $143.73 $264,495 - $304,420
2,118 New
2,118 $303,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $176B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Carmignac Gestion Portfolio

Follow Carmignac Gestion and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carmignac Gestion, based on Form 13F filings with the SEC.

News

Stay updated on Carmignac Gestion with notifications on news.